These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

271 related articles for article (PubMed ID: 12857984)

  • 21. Effects of cytokines on acetylcholine receptor expression: implications for myasthenia gravis.
    Poëa-Guyon S; Christadoss P; Le Panse R; Guyon T; De Baets M; Wakkach A; Bidault J; Tzartos S; Berrih-Aknin S
    J Immunol; 2005 May; 174(10):5941-9. PubMed ID: 15879086
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Enzyme-linked immunosorbent assay for antibody against the nicotinic acetylcholine receptor in human myasthenia gravis.
    Kawanami S; Tsuji R; Oda K
    Ann Neurol; 1984 Feb; 15(2):195-200. PubMed ID: 6367620
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Immunopathogenesis and treatment of myasthenia gravis.
    Levinson AI; Zweiman B; Lisak RP
    J Clin Immunol; 1987 May; 7(3):187-97. PubMed ID: 3036906
    [No Abstract]   [Full Text] [Related]  

  • 24. Myasthenia gravis and the neuromuscular junction.
    Querol L; Illa I
    Curr Opin Neurol; 2013 Oct; 26(5):459-65. PubMed ID: 23945282
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Pseudo-internuclear ophthalmoplegia in myasthenia gravis].
    Bogdan I; Crisanda V
    Oftalmologia; 2011; 55(3):70-3. PubMed ID: 22428294
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Antibody effector mechanisms in myasthenia gravis-pathogenesis at the neuromuscular junction.
    Gomez AM; Van Den Broeck J; Vrolix K; Janssen SP; Lemmens MA; Van Der Esch E; Duimel H; Frederik P; Molenaar PC; Martínez-Martínez P; De Baets MH; Losen M
    Autoimmunity; 2010 Aug; 43(5-6):353-70. PubMed ID: 20380584
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The thymus in myasthenia gravis: Site of "innate autoimmunity"?
    Cavalcante P; Le Panse R; Berrih-Aknin S; Maggi L; Antozzi C; Baggi F; Bernasconi P; Mantegazza R
    Muscle Nerve; 2011 Oct; 44(4):467-84. PubMed ID: 21922466
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Determinant spreading and immune responses to acetylcholine receptors in myasthenia gravis.
    Vincent A; Willcox N; Hill M; Curnow J; MacLennan C; Beeson D
    Immunol Rev; 1998 Aug; 164():157-68. PubMed ID: 9795773
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Humoral antibodies to acetylcholine receptor in patients with myasthenia gravis.
    Aharonov A; Abramsky O; Tarrab-Hazdai R; Fuchs S
    Lancet; 1975 Aug; 2(7930):340-2. PubMed ID: 51144
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Anti-MuSK patient antibodies disrupt the mouse neuromuscular junction.
    Cole RN; Reddel SW; Gervásio OL; Phillips WD
    Ann Neurol; 2008 Jun; 63(6):782-9. PubMed ID: 18384168
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Myasthenia gravis. Prototype of an anti-receptor autoaggression disease (author's transl)].
    Hohlfeld R; Wekerle H
    MMW Munch Med Wochenschr; 1981 Jul; 123(31):1207-11. PubMed ID: 6790965
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Somatic hypermutation and selection of B cells in thymic germinal centers responding to acetylcholine receptor in myasthenia gravis.
    Sims GP; Shiono H; Willcox N; Stott DI
    J Immunol; 2001 Aug; 167(4):1935-44. PubMed ID: 11489973
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Acetylcholine receptors and myasthenia gravis.
    Vincent A
    Clin Endocrinol Metab; 1983 Mar; 12(1):57-78. PubMed ID: 6303649
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Increased binding of anti-acetylcholine receptor antibodies to thymic antigen in patients with myasthenia gravis and other autoimmune diseases, as compared to those with myasthenia gravis alone.
    Morel E; Raimond F; Bach JF
    J Neuroimmunol; 1987 Mar; 14(2):221-6. PubMed ID: 3818943
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Immunologic studies of the role of cholinergic receptors in the pathogenesis of myasthenia gravis].
    Członkowski A; Członkowska A
    Neurol Neurochir Pol; 1978; 12(5):633-7. PubMed ID: 214726
    [No Abstract]   [Full Text] [Related]  

  • 36. [Myasthenia gravis induced by autoantibodies against MuSK].
    Shigemoto K; Konishi T; Ohta M
    Nihon Rinsho; 2008 Jun; 66(6):1149-54. PubMed ID: 18540361
    [TBL] [Abstract][Full Text] [Related]  

  • 37. An acetylcholine receptor alpha subunit promoter confers intrathymic expression in transgenic mice. Implications for tolerance of a transgenic self-antigen and for autoreactivity in myasthenia gravis.
    Salmon AM; Bruand C; Cardona A; Changeux JP; Berrih-Aknin S
    J Clin Invest; 1998 Jun; 101(11):2340-50. PubMed ID: 9616205
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Myasthenia gravis (first of two parts).
    Drachman DB
    N Engl J Med; 1978 Jan; 298(3):136-42. PubMed ID: 201840
    [No Abstract]   [Full Text] [Related]  

  • 39. [Physiopathology of myasthenia gravis. A review (author's transl)].
    Bergmans J
    Ann Chir; 1980 Mar; 34(3):147-57. PubMed ID: 6245616
    [No Abstract]   [Full Text] [Related]  

  • 40. Nature and Action of Antibodies in Myasthenia Gravis.
    Ruff RL; Lisak RP
    Neurol Clin; 2018 May; 36(2):275-291. PubMed ID: 29655450
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.